Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial

Filip Krag Knop; Debora P.  Cabral; Juan P Frias; Manjunatha  Revanna; Anette L.  Søndergaard; Vanita R Aroda

doi:10.1089/dia.2024.2525.abstracts

Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial

Filip Krag Knop, Debora P. Cabral, Juan P Frias, Manjunatha Revanna, Anette L. Søndergaard, Vanita R Aroda

Original language	English
Article number	O023 / #680
Journal	Diabetes Technology & Therapeutics
Volume	26
Issue number	s2
ISSN	1520-9156
DOIs	https://doi.org/10.1089/dia.2024.2525.abstracts
Publication status	Published - Feb 2024
Event	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes - Florence, Italy Duration: 6 Mar 2024 → 9 Mar 2024 https://attd.kenes.com/

Conference

Conference	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes
Country/Territory	Italy
City	Florence
Period	06/03/2024 → 09/03/2024
Internet address	https://attd.kenes.com/

Access to Document

10.1089/dia.2024.2525.abstracts

Cite this

Knop, F. K., Cabral, D. P., Frias, J. P., Revanna, M., Søndergaard, A. L., & Aroda, V. R. (2024). Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial. Diabetes Technology & Therapeutics, 26(s2), Article O023 / #680 . https://doi.org/10.1089/dia.2024.2525.abstracts

Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial. / Knop, Filip Krag; Cabral, Debora P. ; Frias, Juan P et al.
In: Diabetes Technology & Therapeutics, Vol. 26, No. s2, O023 / #680 , 02.2024.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Knop, FK, Cabral, DP, Frias, JP, Revanna, M, Søndergaard, AL & Aroda, VR 2024, 'Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial', Diabetes Technology & Therapeutics, vol. 26, no. s2, O023 / #680 . https://doi.org/10.1089/dia.2024.2525.abstracts

Knop FK, Cabral DP, Frias JP, Revanna M, Søndergaard AL, Aroda VR. Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial. Diabetes Technology & Therapeutics. 2024 Feb;26(s2):O023 / #680 . doi: 10.1089/dia.2024.2525.abstracts

@article{1e70ac11cdd040928236452bc3bc4551,

title = "Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial",

author = "Knop, \{Filip Krag\} and Cabral, \{Debora P.\} and Frias, \{Juan P\} and Manjunatha Revanna and S{\o}ndergaard, \{Anette L.\} and Aroda, \{Vanita R\}",

year = "2024",

month = feb,

doi = "10.1089/dia.2024.2525.abstracts",

language = "English",

volume = "26",

journal = "Diabetes Technology \& Therapeutics",

issn = "1520-9156",

publisher = "SAGE Publications Ltd",

number = "s2",

note = "ATTD 2024 - 17th International Conference on Advanced Technologies \& Treatments for Diabetes, ATTD 2024 ; Conference date: 06-03-2024 Through 09-03-2024",

url = "https://attd.kenes.com/",

}

TY - ABST

T1 - Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial

AU - Knop, Filip Krag

AU - Cabral, Debora P.

AU - Frias, Juan P

AU - Revanna, Manjunatha

AU - Søndergaard, Anette L.

AU - Aroda, Vanita R

PY - 2024/2

Y1 - 2024/2

U2 - 10.1089/dia.2024.2525.abstracts

DO - 10.1089/dia.2024.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 26

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - s2

M1 - O023 / #680

T2 - ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes

Y2 - 6 March 2024 through 9 March 2024

ER -